Oral antimicrobial therapy for diabetic foot osteomyelitis

Foot and Ankle International

Volumn 27, Issue 10, 2006, Pages 771-779

  Embil, John M ^a,b,c   Rose, Greg ^a,d   Trepman, Elly ^a,b,c   Math, Mary Cheang M ^a,b   Duerksen, Frank ^a,b,c   Simonsen, J Neil ^a,e   Nicolle, Lindsay E ^a,b,c  

^a University of Manitoba ^*

^b UNIVERSITY OF MANITOBA   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Complications; Diabetes; Infection; Neuropathy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ITRACONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; TETRACYCLINE;

ACINETOBACTER BAUMANNII; ADULT; AEROBIC BACTERIUM; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; AMPUTATION; ANAEROBIC BACTERIUM; ANKLE BRACHIAL INDEX; ANTIMICROBIAL THERAPY; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; BETA HEMOLYTIC STREPTOCOCCUS; CITROBACTER FREUNDII; CITROBACTER KOSERI; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEBRIDEMENT; DIABETIC FOOT; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; FOLLOW UP; FOOT RADIOGRAPHY; GRAM POSITIVE COCCI; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORGANELLA MORGANII; OSTEOMYELITIS; PEPTOSTREPTOCOCCUS; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PUTIDA; RELAPSE; REMISSION; RETROSPECTIVE STUDY; REVIEW; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS MILLERI; TOE; TREATMENT DURATION;

EID: 33749337567     PISSN: 10711007     EISSN: None     Source Type: Journal    
DOI: 10.1177/107110070602701003     Document Type: Review

References (52)

1. Attinger, CE; Bulan, EJ: Debridement. The key initial first step in wound healing. Foot Ankle Clin. 6:627-660, 2001.
2. Badgley, RF: Social and economic disparities under Canadian health care. Int. J. Health Serv. 21:659-671, 1991.
3. Bamberger, DM; Daus, GP; Gerding, DN: Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am. J. Med. 83:653-660, 1987.
4. Benton, GS; Kerstein, MD: Cost effectiveness of early digit amputation in the patient with diabetes. Surg. Gyn. Obstet. 161:523-524, 1985.
5. Cierny, G 3rd; Mader, JT: Adult chronic osteomyelitis. Orthopedics 7:1557-1564, 1984.
6. Embil, J; Almuneef, M; Nicoll, D; et al.: Methicillin-resistant Staphylococcus aureus: profiles oceans apart - Canadian and Saudi Arabian experiences. J. Chemother. 13 (Suppl. 1):28-33, 2001.
7. Embil, JM; Choudhri, SH; Germaine, G; et al.: Community Intravenous Therapy Program and a treatment plan for foot infections in persons with diabetes: a clinical perspective. Can. J. Infect. Dis. 11 (Suppl. A):49A-56A, 2000.
8. Ge, Y; MacDonald, D; Hait, H; et al.: Microbiological profile of infected diabetic foot ulcers. Diab. Med. 19:1032-1034, 2002.
9. Gerding, DN: Foot infections in diabetic patients: the role of anaerobes. Clin. Infect. Dis. 20 (Suppl. 2):S283-S288, 1995.
10. Gerding, DN; Huges, CE; Bamberger, DM; Foxworth, J; Larson, TA: Extravascular antimicrobial distribution and the respective blood concentrations in humans. In V Lorian (eds.), Antibiotics in Laboratory Medicine, 4th edition. Williams & Wilkins, Baltimore, pp. 835-899, 1996.
11. Grayson, ML; Gibbons, GW; Balogh, K; Levin, E; Karchmer, AW: Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. J. Am. Med. Assoc. 273:721-723, 1995.
12. Ha Van, G; Siney, H; Danan, JP; Sachen, C; Grimaldi, A: Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery. Diab. Care 19:1257-1260, 1996.
13. Haas, DW; McAndrew, MP: Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am. J. Med. 101:550-561, 1996.
14. Hedström, SÅ: General and local antibiotic treatment of chronic osteomyelitis. Scand. J. Infect. Dis. 1:175-180, 1969.
15. Hedström, SÅ: The prognosis of chronic staphylococcal osteomyelitis after long-term antibiotic treatment. Scand. J. Infect. Dis. 6:33-38, 1974.
16. Hunt, JA: Foot infections in diabetes are rarely due to a single microorganism. Diab. Med. 9:749-752, 1992.
17. Jeffcoate, WJ; Lipsky, BA: Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin. Infect. Dis. 39 (Suppl. 2):S115-S122, 2004.
18. Johnson, MK; Rybczynski, J; Kanat, IO: Hallux amputation for diabetic osteomyelitis. J. Foot Surg. 26:141-148, 1987.
19. Kapral, MK; Wang, H; Mamdani, M; Tu, JV: Effect of socioeconomic status on treatment and mortality after stroke. Stroke 33:268-273, 2002.
20. Katz, SJ; Zemencuk, JK; Hofer, TP: Breast cancer screening in the United States and Canada, 1994: socioeconomic gradients persist. Am. J. Public Health 90:799-803, 2000.
21. Kelly, C; Booth, GL: Diabetes in Canadian women. BMC Womens Health 4 (Suppl. 1):S16, 2004.
22. Lew, DP; Waldvogel, FA: Osteomyelitis. Lancet 364:369-379, 2004.
23. Lew, DP; Waldvogel, FA: Osteomyelitis. New Engl. J. Med. 336:999-1007, 1997.
24. Lew, DP; Waldvogel, FA: Use of quinolones in osteomyelitis and infected orthopaedic prosthesis. Drugs 58 (Suppl. 2):85-91, 1999.
25. Lipsky, BA: Osteomyelitis of the foot in diabetic patients. Clin. Infect. Dis. 25:1318-1326, 1997.
26. Lipsky, BA; Berendt, AR; Deery, HG; et al.: Diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis. 39:885-910, 2004.
27. Louie, TJ; Bartlett, JG; Tally, FP; Gorbach, SL: Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann. Intern. Med. 85:461-463, 1976.
28. MacGregor, RR; Graziani, AL: Oral administration of antibiotics: a rational alternative to the parenteral route. Clin. Infect. Dis. 24:457-467, 1997.
29. Mackowiak, PA; Jones, SR; Smith, JW: Diagnostic value of sinus-tract cultures in chronic osteomyelitis. J. Am. Med. Assoc. 239:2772-2775, 1978.
30. Most, RS; Sinnock, P: The epidemiology of lower extremity amputations in diabetic individuals. Diab. Care 6:87-91, 1983.
31. Newbold, KB: Problems in search of solutions: health and Canadian aboriginals. J. Community Health 23:59-73, 1998.
32. Newman, LG; Waller, J; Palestro, CJ; et al.: Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium In 111 oxyquinoline. J. Am. Med. Assoc. 266:1246-1251, 1991.
33. Nix, DE; Cumbo, TJ; Kuritzky, P; Devito, JM; Schentag, JJ: Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety and pharmacokinetics. Am. J. Med. 82 (Suppl. 4A):146-153, 1987.
34. Norden, CW: Lessons learned from animal models of osteomyelitis. Rev. Infect. Dis. 10:103-110, 1988.
35. Perencevich, EN; Kaye, KS; Strausbaugh, LJ; Fisman, DN; Harris, AD: Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultants. Clin. Infect. Dis. 38:476-482, 2004.
36. Peterson, LR; Lissack, LM; Canter, K; et al.: Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am. J. Med. 86:801-808, 1989.
37. Pezzelo, M: Aerobic Bacteriology. In HD Isenberg (eds.) Clinical Microbiology Procedures Handbook. American Society of Microbiology, Washington DC, pp. 1.20.1-1.20.44, 1992.
38. Pezzelo, M: Anaerobic Bacteriology. In HD Isenberg (eds.) Clinical Microbiology Procedures Handbook. American Society of Microbiology, Washington DC, pp. 1.19.1-1.19.104, 1992.
39. Pittet, D; Wyssa, B; Herter-Clavel, C; et al.: Outcome of diabetic foot infections treated conservatively. Arch. Intern. Med. 159:851-856, 1999.
40. Prokesch, RC; Hand, WL: Antibiotic entry into human polymorphonuclear leukocytes, Antimicrob. Agents Chemother. 21:373-380, 1982.
41. Sapico, FL; Canawati, HN; Witte, JL; et al.: Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J. Clin. Microbiol. 12:413-420, 1980.
42. Senneville, E; Yazdanpanah, Y; Cazaubiel, M; et al.: Rifampicinofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J. Antimicrob. Chemother. 48:927-930, 2001.
43. Sin, DD; Svenson, LW; Cowie, RL; Man, SF: Can universal access to health care eliminate health inequities between children of poor and nonpoor families? A case study of childhood asthma in Alberta. Chest 124:51-56, 2003.
44. Smith, DG; Stuck, RM; Ketner, L; Sage, RM; Pinzur, MS: Partial calcanectomy for the treatment of large ulcerations of the heel and calcaneal osteomyelitis: an amputation of the back of the foot. J. Bone Joint Surg. 74-A:571-576, 1992.
45. Steed, DL; Edington, H; Moosa, HH; Webster, MW: Organization and development of a university multidisciplinary wound care clinic. Surgery 114:775-779, 1993.
46. Tice, AD; Hoaglund, PA; Shoultz, DA: Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am. J. Med. 114:723-728, 2003.
47. Venkatesan, P; Lawn, S; Macfarlane, RM; et al.: Conservative management of osteomyelitis in the feet of diabetic patients. Diab. Med. 14:487-490, 1997.
48. Veugelers, PJ; Yip, AM: Socioeconomic disparities in health care use: Does universal coverage reduce inequalities in health? J. Epidemiol. Community Health 57:424-428, 2003.
49. Wagner, FW: The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2:64-122, 1981.
50. Wheat, LJ; Allen, SD; Henry, M; et al.: Diabetic foot infections. Bacteriologic analysis. Arch. Intern. Med. 146:1935-1940, 1986.
51. Wilson, KH; Kauffman, CA: Oral antibiotic therapy for osteomyelitis of the foot in diabetic patients. South. Med. J. 78:223-224, 1985.
52. Yadlapalli, NG; Vaishnav, A; Sheehan, P: Conservative management of diabetic foot ulcers complicated by osteomyelitis. Wounds 14:31-35, 2002.